Latest Cardiovascular Disease (CVD) News
The researchers found that over the study period statin use was associated with an 18% lower risk of all-cause mortality and non-significantly lower risk of CVD events and stroke.
Adherence to beta-blockers may not be as beneficial to patients after myocardial infarction.
The results demonstrated a tendency for a decrease in LDL-C level at 24 weeks in the ANA group, and improvement was mediated through the suppression of apoB-100 synthesis.
Administration of exenatide in patients with type 2 diabetes at a wide range of cardiovascular risk appeared not to cause an increase in their overall cardiovascular risk.
The researchers found that there was no evidence of an independent correlation between impaired cognitive function and antihypertensive use.
No associations were seen between low-density lipoprotein cholesterol levels and cognitive changes in an exploratory analysis.
The use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo.
The researchers found that there was an increase in NOAC use over time, warfarin use did not change, and overall anticoagulant use increased.
Older age, Indian ethnicity, hypertension, chronic kidney disease, creatinine level, glomerular filtration rate, and history of stroke were associated with prevalent retinal emboli in multivariable-adjusted analysis.
Canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo.
In a study, the risk for heart failure was 81% higher among patients who received androgen deprivation therapy.
High-carb diets were associated with a 28% increased risk of death vs low-carb diets.
Liraglutide-treated patients were 22% less likely than placebo recipients to experience a composite outcome of renal events.
ApoB is a superior marker of cardiovascular disease risk than LDL-C.
The researchers found patients on intensive blood pressure treatment fared as well as those on standard care.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)